Relapsing Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Relapsing Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-07-18Clinical Trial Update: A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis [Phase 3]
A Phase 3 trial comparing ocrelizumab with interferon beta-1a in relapsing multiple sclerosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Natalizumab as an Efficacy Switch in Participants With Relapsing Multiple Sclerosis After Failure on Other Therapies [Phase 4]
A Phase 4 trial evaluated switching to natalizumab in participants with relapsing multiple sclerosis after failure on other therapies; the s…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients [Phase 3]
Phase 3 trial update reports tolerability, safety, and health outcomes in relapsing multiple sclerosis and notes completion of the study.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017) [Phase 3]
Phase 3 trial update examining flu-like symptoms in relapsing multiple sclerosis patients switching from non-pegylated interferon beta thera…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Long-Term Safety and Efficacy Study of Peginterferon Beta-1a [Phase 3]
Phase 3 long-term safety and efficacy study of peginterferon beta-1a in relapsing multiple sclerosis completed, with results posted in 2017.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-09-29Clinical Trial Update: JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab
Clinical trial update describing a completed study that evaluates JC virus antibody status in participants with relapsing multiple sclerosis…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: A Phase 2 Study of Atacicept in Subjects With Relapsing Multiple Sclerosis (ATAMS) [Phase 2]
This update reports results from a Phase 2 study of atacicept in relapsing multiple sclerosis (ATAMS). The trial was terminated and results …
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Atacicept in Multiple Sclerosis Extension Study, Phase II [Phase 2]
Phase II extension study of atacicept in relapsing multiple sclerosis was terminated. Results were posted in 2016.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Impact of Disease Modifying Therapies (DMTs) and Associated Support Services in Relapsing Multiple Sclerosis (RMS) Patients
This clinical trial update assesses the impact of disease-modifying therapies and associated support services on patients with Relapsing Mul…
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: Efficacy and Safety Study of Peginterferon Beta-1a in Participants With Relapsing Multiple Sclerosis [Phase 3]
A Phase 3 trial evaluating the efficacy and safety of peginterferon beta-1a in relapsing multiple sclerosis has completed and results have b…
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of teriflunomide in relapsing multiple sclerosis patients treated with interferon-beta; th…
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial [Phase 4]
Phase 4 trial comparing REBIF (interferon beta-1a) with Glatiramer Acetate in relapsing multiple sclerosis. Results were posted in 2014 and …
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device
This completed observational retrospective audit in the UK & Ireland evaluated patient adherence to Rebif injections when using the RebiSmar…
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Effect of Treatment With Fingolimod on the Immune Response Following Seasonal Flu Vaccination and Tetanus Booster Injection in Patients With Relapsing Multiple Sclerosis (MS) [Phase 3]
Phase 3 study evaluating the effect of fingolimod on immune responses to seasonal influenza vaccination and tetanus booster in relapsing mul…
-
CLINICAL_TRIALS trial_result · 2011-11-10Clinical Trial Update: Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study [Phase 2]
A Phase 2 safety study of Trichuris suis ova therapy for relapsing multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2011-09-12Clinical Trial Update: CDP323 Biomarker Study [Phase 1, Phase 2]
This document reports the completion of a Phase 1/Phase 2 biomarker study of CDP323 in relapsing multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2010-07-26Clinical Trial Update: Transition to Rebif New Formulation [Phase 3]
Phase 3 trial update on transitioning to a new Rebif formulation for relapsing multiple sclerosis; results were posted in July 2010.
-
CLINICAL_TRIALS trial_result · 2010-01-27Clinical Trial Update: Study to Determine if Avonex and Rebif Work Comparably Well in Subjects With Relapsing Multiple Sclerosis
Biogen-sponsored clinical trial has completed comparing Avonex and Rebif to determine if they work comparably in relapsing multiple sclerosi…
-
CLINICAL_TRIALS trial_result · 2009-09-02Clinical Trial Update: Rebif New Formulation (RNF) Quality of Life (QOL) Study [Phase 3]
Phase 3 study evaluating Rebif New Formulation (RNF) for quality of life in relapsing multiple sclerosis; completed with results posted in 2…